STAT October 3, 2023
The Food and Drug Administration on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving Americans seeking to update their protection against the SARS-CoV-2 virus another option.
Though the FDA’s green light came three weeks after the approvals for the updated Moderna and Pfizer-BioNTech shots, it contained some welcome news for the Gaithersburg, Md.-based company, which has struggled to claim a share of the now dwindling Covid vaccine market — globally and within the United States.
Previous rules established by the FDA and the Centers for Disease Control and Prevention limited use of this vaccine to people aged 12 and older who had either not had a primary series of Covid vaccinations or who had a primary series and only one booster,...
Today's Sponsors
Today's Sponsor